Pacira BioSciences [PCRX] vs Perrigo Company plc [PRGO] Detailed Stock Comparison

Pacira BioSciences Inc.

NASDAQ
Loading...

Perrigo Company plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Pacira BioSciences Inc. wins in 8 metrics, Perrigo Company plc wins in 11 metrics, with 0 ties. Perrigo Company plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pacira BioSciences Inc. Perrigo Company plc Better
P/E Ratio (TTM) 154.00 2,818.00 Pacira BioSciences Inc.
Price-to-Book Ratio 1.46 0.55 Perrigo Company plc
Debt-to-Equity Ratio 60.34 131.16 Pacira BioSciences Inc.
PEG Ratio -1.74 0.91 Perrigo Company plc
EV/EBITDA 9.47 7.26 Perrigo Company plc
Profit Margin (TTM) 0.97% -33.51% Pacira BioSciences Inc.
Operating Margin (TTM) -1.17% 10.20% Perrigo Company plc
EBITDA Margin (TTM) N/A 10.20% N/A
Return on Equity 0.96% -38.66% Pacira BioSciences Inc.
Return on Assets (TTM) 1.48% 2.35% Perrigo Company plc
Free Cash Flow (TTM) $136.66M $145.10M Perrigo Company plc
Dividend Yield N/A 9.92% N/A
1-Year Return -10.14% -58.72% Pacira BioSciences Inc.
Price-to-Sales Ratio (TTM) 1.46 0.38 Perrigo Company plc
Enterprise Value $1.18B $4.93B Perrigo Company plc
EV/Revenue Ratio 1.62 1.16 Perrigo Company plc
Gross Profit Margin (TTM) 79.53% 32.64% Pacira BioSciences Inc.
Revenue per Share (TTM) $16 $31 Perrigo Company plc
Earnings per Share (Diluted) $0.16 $-10.12 Pacira BioSciences Inc.
Beta (Stock Volatility) 0.20 0.49 Pacira BioSciences Inc.
Short % of Float 29.98% 18.67% Perrigo Company plc

Pacira BioSciences Inc. vs Perrigo Company plc Stock Performance Analysis

Loading Price Chart...

PCRX
PRGO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pacira BioSciences Inc.0.31%-8.70%-9.92%4.51%-7.60%-9.08%
Perrigo Company plc0.00%-3.15%-8.17%-15.24%-23.14%-24.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pacira BioSciences Inc.-10.14%-40.60%-61.90%-50.69%67.77%230.30%
Perrigo Company plc-58.72%-66.51%-76.52%-88.64%-86.89%-34.38%

Performance & Financial Health Analysis: Pacira BioSciences Inc. vs Perrigo Company plc

MetricPCRXPRGO
Market Information
Market Cap i$1.09B$1.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i455,1442,169,621
90 Day Avg. Volume i642,2013,503,450
Last Close$22.32$10.46
52 Week Range$18.80 - $27.64$9.23 - $28.44
% from 52W High-19.25%-63.22%
All-Time High$121.95 (Feb 23, 2015)$215.73 (Apr 06, 2015)
% from All-Time High-81.70%-95.15%
Growth Metrics
Quarterly Revenue Growth0.05%-0.03%
Quarterly Earnings Growth-0.90%-0.03%
Financial Health
Profit Margin (TTM) i0.01%-0.34%
Operating Margin (TTM) i-0.01%0.10%
Return on Equity (TTM) i0.01%-0.39%
Debt to Equity (MRQ) i60.34131.16
Cash & Liquidity
Book Value per Share (MRQ)$16.86$21.33
Cash per Share (MRQ)$5.89$3.86
Operating Cash Flow (TTM) i$151.99M$238.50M
Levered Free Cash Flow (TTM) i$108.56M$28.33M
Dividends
Last 12-Month Dividend Yield iN/A9.92%
Last 12-Month Dividend iN/A$1.16

Valuation & Enterprise Metrics Analysis: Pacira BioSciences Inc. vs Perrigo Company plc

MetricPCRX (Apr 24, 2026)PRGO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i154.002,818.00
Forward P/E i7.024.93
PEG Ratio i-1.740.91
Price to Sales (TTM) i1.460.38
Price to Book (MRQ) i1.460.55
Market Capitalization
Market Capitalization i$1.09B$1.61B
Enterprise Value i$1.18B$4.93B
Enterprise Value Metrics
Enterprise to Revenue i1.621.16
Enterprise to EBITDA i9.477.26
Risk & Other Metrics
Beta i0.200.49
Book Value per Share (MRQ) i$16.86$21.33

Financial Statements Comparison: Pacira BioSciences Inc. vs Perrigo Company plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPCRX (2025)PRGO (2025)
Revenue/Sales i726.41M4.25B
Cost of Goods Sold i149.75M2.76B
COGS % of Revenue i20.6%64.9%
Gross Profit i576.66M1.49B
Gross Margin i79.4%35.1%
Research & Development i117.31M95.40M
Operating Income (EBIT) i33.30M312.80M
Operating Margin i4.6%7.4%
EBITDA i137.60M637.10M
EBITDA Margin i18.9%15.0%
Pre-Tax Income i16.87M-1.30B
Pre-Tax Income % of Revenue i2.3%-30.5%
Income Tax i9.84M104.40M
Income Tax % of Revenue i1.4%2.5%
Net Income (Profit) i7.03M-1.43B
Profit Margin i1.0%-33.5%

Balance Sheet & Liquidity Metrics

MetricPCRX (2025)PRGO (2025)
Cash & Equivalents i158.55M531.60M
Total Current Assets i547.97M2.80B
Total Current Assets % of Revenue i75.4%65.8%
Total Current Liabilities i120.59M1.01B
Total Current Liabilities % of Revenue i16.6%23.8%
Long-Term Debt i408.37M3.60B
Long-Term Debt % of Revenue i56.2%84.7%
Total Shareholders Equity i693.11M2.94B
Retained Earnings i-199.32M-3.68B
Retained Earnings % of Revenue i-27.4%-86.5%
Property, Plant & Equipment i41.78M167.80M

Cash Flow Statement Comparison

MetricPCRX (2025)PRGO (2025)
Operating Cash Flow i108.50M-1.06B
Operating Cash Flow % of Revenue i14.9%-24.9%
Capital Expenditures i-15.33M-93.40M
Free Cash Flow i136.66M145.10M
FCF Margin i18.8%3.4%
Debt Repayment i-317.80M-34.80M
Common Stock Repurchase i-148.33MN/A

Short Interest & Institutional Ownership Analysis

MetricPCRXPRGO
Shares Short i8.06M16.69M
Short Ratio i9.813.99
Short % of Float i29.98%18.67%
Shares Outstanding i41.12M137.62M
Float Shares i37.64M136.81M
% Held by Insiders i3.32%0.41%
% Held by Institutions i118.71%115.48%
% Held by Public i-22.03%-15.89%

Dividend Analysis & Yield Comparison: Pacira BioSciences Inc. vs Perrigo Company plc

MetricPCRXPRGO
Last 12-Month Dividend iN/A$1.16
Last 12-Month Dividend Yield iN/A9.92%
3-Year Avg Annual Dividend iN/A$1.12
3-Year Avg Dividend Yield iN/A1.09%
3-Year Total Dividends iN/A$3.36
Ex-Dividend DateN/AMar 02, 2026